Severe hypertriglyceridemia associated with everolimus drug-eluting stent placement in an infant.
Cardiol Young
; 29(4): 541-543, 2019 Apr.
Article
em En
| MEDLINE
| ID: mdl-30957734
ABSTRACT
We report a case of severe hypertriglyceridemia associated with an everolimus drug-eluting stent in an infant with pulmonary vein stenosis. We review from current literature the mechanisms by which everolimus may cause dyslipidaemia, pharmacokinetics of everolimus in drug-eluting stents, and treatments of hypertriglyceridemia. This case demonstrates the need to closely monitor serum triglyceride levels after everolimus drug-eluting stent placement in infants.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Hipertrigliceridemia
/
Stents Farmacológicos
/
Everolimo
/
Estenose de Veia Pulmonar
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
/
Infant
/
Male
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article